Industry reports
Editor highlights

Global Generic Pharmaceuticals Industry Report

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Search ReportLinker

The Largest Collection of Market Research Reports

» 1.2 Million Industry Reports
» 450,000 Company Profiles
» 850,000 Market Briefings
» 40,000 Country Guides

From +200,000 authoritative sources

DOWNLOAD THESE REPORTS NOW!

Global Generic Drugs Market 2014-2018

Global Generic Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • by Infiniti Research Limited
  • March 2014
  • 95 pages

TechNavio's analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. ...

Industries: Generic Drug | Countries: World

Ibandronic Acid - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Ibandronic Acid - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available),

Industries: Generic Drug | Countries: World

Hirudin - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

Hirudin - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

  • $ 1 105
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available),

Industries: Generic Drug | Countries: World

Rasagiline - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

Rasagiline - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

  • $ 1 105
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available),

Industries: Generic Drug | Countries: World

Vardenafil - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

Vardenafil - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

  • $ 1 105
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available),

Industries: Generic Drug | Countries: World

Silodosin - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

Silodosin - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

  • $ 1 105
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available),

Industries: Generic Drug | Countries: World

Imatinib - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Imatinib - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available),

Industries: Generic Drug | Countries: World

Tolterodine - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Tolterodine - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available),

Industries: Generic Drug | Countries: World

Latanoprost - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

Latanoprost - Key patent, SPC, and data exclusivity expiry (44 countries coverage)

  • $ 1 105
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available),

Industries: Generic Drug | Countries: World

Zoledronic Acid - Key patent, SPC, and data exclusivity expiry (7 country coverage)

Zoledronic Acid - Key patent, SPC, and data exclusivity expiry (7 country coverage)

  • $ 460
  • Industry report
  • by GenericsWeb
  • March 2014

Pipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available),

Industries: Generic Drug | Countries: World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.